Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
03/2003
03/26/2003EP1294765A2 Il-17 molecules and uses thereof
03/26/2003EP1294752A2 Angiogenesis-modulating compositions and uses
03/26/2003EP1294740A2 Chemically-modified antimicrobial peptides, compositions and methods of production and use
03/26/2003EP1294728A1 HMG-CoA REDUCTASE INHIBITORS AND METHOD
03/26/2003EP1294725A2 Multicyclic compounds and the use thereof as inhibitors of parp, vegfr2 and mlk3 enzymes
03/26/2003EP1294724A1 Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents
03/26/2003EP1294718A2 6,5-fused bicyclic heterocycles
03/26/2003EP1294715A1 Quinazoline ditosylate salt compounds
03/26/2003EP1294711A2 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as as modulators of protein kinases
03/26/2003EP1294707A2 Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
03/26/2003EP1294700A2 Benzhydryl derivatives
03/26/2003EP1294691A1 Serine protease inhibitors
03/26/2003EP1294690A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
03/26/2003EP1294688A2 Indolinone derivatives as protein kinase/phosphatase inhibitors
03/26/2003EP1294687A2 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase
03/26/2003EP1294686A2 Indole derivatives and their use as 15-lipoxygenase inhibitors
03/26/2003EP1294681A2 Fmoc-l-leucine and derivatives thereof as ppar- gamma agonists
03/26/2003EP1294413A1 Sprayable wound care compositions
03/26/2003EP1294409A2 Membrane-permeant peptide complexes for medical imaging
03/26/2003EP1294391A2 Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking lfa-1 mediated adhesion
03/26/2003EP1294375A2 Method of treatment of seborrheic dermatitis
03/26/2003EP1294374A1 Flavone/flavanone derivatives for the systemic treatment and prophylaxis of uv-induced dermatoses
03/26/2003EP1294355A1 Use of inulin and inulin derivatives
03/26/2003EP1294354A1 Use of inulins and inulin derivatives
03/26/2003EP1294352A1 Cosmetic treatment and device
03/26/2003EP1294349A2 Use of egf-r protein tyrosine kinase inhibitors for preventing photoaging in human skin
03/26/2003EP1185528A4 Inhibitors of il-12 production
03/26/2003EP1146873A4 Anti-androgens and methods for treating disease
03/26/2003EP1105384B1 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
03/26/2003EP0998454B1 Metalloproteinase inhibitors
03/26/2003EP0930310B1 Isocoumarin derivatives and use thereof in drugs
03/26/2003EP0841931B1 Pharmaceutical composition
03/26/2003CN1406237A Novel benzosultam oxazolidinone antibacterial agents
03/26/2003CN1406230A 2,4-di (hetero-) arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents
03/26/2003CN1406229A Pyrimidine compounds
03/26/2003CN1406225A Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists
03/26/2003CN1406133A New uses of insulin and pancreatin
03/26/2003CN1406132A Method for treating or inhibiting cellular injury or cell death
03/26/2003CN1406127A Thiazolium compounds and treatments of disorders associated with protein aging
03/26/2003CN1405314A Cryptoporus volvatus fermented product, and its preparation method and application
03/26/2003CN1405164A Corter pseudolaricis acid derivatives, preparation method and use thereof
03/26/2003CN1404869A Medicine for treating burn and scald and preparation method thereof
03/26/2003CN1404858A Shaoshangling-medicine for treating fire burn
03/26/2003CN1404856A Water-soluble ginger-root extract
03/26/2003CN1404855A Medicine for treating scald
03/26/2003CN1404829A Double inhibitor synthesized by wax ester and cholesterol ester for inbibiting generation of sebum
03/26/2003CN1404828A Use of pantethine sulfonic acid and/or its salt as free radical scavenger
03/26/2003CN1404819A Skin-care composition changing colour when dry
03/26/2003CN1103760C 1,3-dihydro-2H-imidazol-2-one derivatives having PDEIV and cytokinin inhibiting activity
03/26/2003CN1103755C Novel structural analogues of vitamin D
03/26/2003CN1103596C Burn-treating medicine powder and its preparation
03/25/2003US6538149 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo [1,2-g]chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
03/25/2003US6538121 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4
03/25/2003US6538103 Anti-angiogenic agents; kringle 1; use treatment of cancer, diabetic retinopathy, rheumatoid arthritis, psoriasis, arteriosclerotic plaque formation
03/25/2003US6538011 Composition for the antidandruff treatment of the hair and scalp based on an antidandruff active principle and on a hydroxy acid
03/25/2003US6538009 Pyrazole derivatives as anti-inflammatory/analgesic agents
03/25/2003US6537984 Contacting a targeted solid tumor cell population with a combination of a vinca alkaloid selected from vinblastine, vincristine, vinorelbine, and a triptolide in combination dosage to reduce the targeted tumor cell population
03/25/2003US6537981 26,27-Homologated-20-EPI-2-alklidene-19-nor-vitamin D compounds
03/25/2003US6537980 Vitamin D analogues and their pharmaceutical use
03/25/2003US6537784 Self-regulated apoptosis of inflammatory cells by gene therapy
03/25/2003US6537591 Aquatic animal treatment method and composition containing Pimenta extract
03/25/2003US6537570 Method of biological control
03/25/2003US6537528 Coloration close to that of a natural tan and which may be stable over time
03/25/2003CA2224093C Human vascular endothelial growth factor 2
03/25/2003CA2201723C Colchicine derivatives and the therapeutical use thereof
03/25/2003CA2200480C New use of prostaglandins
03/20/2003WO2003023404A1 A method of diagnosis and treatment and agents useful for same
03/20/2003WO2003023008A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/20/2003WO2003022877A1 Crystal structure of baff, and use thereof in drug design
03/20/2003WO2003022871A2 Peptides having a c- terminal hydroxylamino group as inhibitors of dipeptidyl peptidase i
03/20/2003WO2003022852A2 Furo-and thienopyrimidine derivatives as angiogenesis inhibitors
03/20/2003WO2003022842A1 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors
03/20/2003WO2003022837A1 Heterocycle-carboxamide derivatives as raf kinase inhibitors
03/20/2003WO2003022835A1 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
03/20/2003WO2003022830A1 Benzothiepine ileal bile acid transport inhibitors
03/20/2003WO2003022814A1 Indole derivatives
03/20/2003WO2003022813A1 Indole derivatives, process for producing the same and drugs containing the same as the active ingredient
03/20/2003WO2003022801A1 Reverse hydroxamic acid derivatives
03/20/2003WO2003022787A1 Method for preparing unsaturated fatty hydroxy-acids and esters thereof, their use in pharmaceutical and/or cosmetic compositions
03/20/2003WO2003022309A1 Remedies for allergic diseases
03/20/2003WO2003022291A1 Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
03/20/2003WO2003022286A1 Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia
03/20/2003WO2003022267A1 Pharmaceutical compositions containing terbinafin and use thereof
03/20/2003WO2003022266A1 Hypoestoxides, derivatives and agonists thereof for use as inhibitors of angiongenesis
03/20/2003WO2003022257A1 External preparations for the skin
03/20/2003WO2003022255A2 Lactic acid bacteria comprising unmethylated cytosine-guanine dinucleotides for use in therapy
03/20/2003WO2003022246A1 Treating effects of excessive reactive oxygen species
03/20/2003WO2003022235A2 Water-in-silicone emulsions
03/20/2003WO2003022231A1 Compositions for stimulating and promoting hair growth
03/20/2003WO2003022218A2 Carboxylate-gated-nitroxide (cgn) compounds and compositions and methods of use thereof
03/20/2003WO2003022217A2 Treatment of excessive radiation (e.g. sunburn) exposure
03/20/2003WO2003011241A8 Utilization of creatinine and/or creatinine derivatives in cosmetic and dermatological preparations
03/20/2003WO2003009898A8 Treatment of hair follicle with neurokinin 1 receptor antagonists
03/20/2003WO2003004046A3 Use of xaa-pro peptidases for the treatment of substance p-related disorders
03/20/2003WO2003002117A3 Niaciamide and derivatives in combination with aminosugar
03/20/2003WO2003002104A3 Use of corrinoids in the treatment of skin diseases
03/20/2003WO2002102808A3 (PYRIDO/THIENO)-[f]-OXAZEPIN-5-ONE DERIVATIVES AS POSITIVE MODULATORS OF THE AMPA RECEPTOR
03/20/2003WO2002102344A3 No-synthase inhibitor and use thereof
03/20/2003WO2002100836A8 Compounds, compositions and methods for modulating beta-amyloid production
03/20/2003WO2002096366A3 Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy
1 ... 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 ... 1065